Work

Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma

Year: 2021

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Digestive Diseases and Sciences

DOI: 10.1007/s10620-021-07156-2

Authors: Bruno Bockorny, Andrea J. Bullock, Thomas A. Abrams, Salomao Faintuch, David C. Alsop, S. Nahum Goldberg, Muneeb Ahmed, Rebecca A. Miksad

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber Cancer Institute, Hadassah Medical Center, Boston University, Boston Medical Center, Flatiron Health (United States)

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Award: Optimizing localized therapy for primary liver cancer: a clinical trial and model

OpenAlex ID: W3184672870

FWCI: 0.555

Cites: 43

Cited by: 5

Related to: 10